Roivant Sciences Ltd. (ROIV) stock
ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
$39.53−0.46 (-1.15%)
Close on Nov 13, 2026Market cap $28.55BP/E –Yield –
Roivant Sciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Roivant Sciences's profit margin for the twelve months ending Sep 30, 2026 was -838.2%. For fiscal 2025 it was -3629.2%, against -592.0% the year before. The highest annual figure on record is 13294.2% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Mar 31, 2026 | -3629.2% | −3037.2 |
| FY2024 | Mar 31, 2025 | -592.0% | −13886.1 |
| FY2023 | Mar 31, 2024 | 13294.2% | +16494.4 |
| FY2022 | Mar 31, 2023 | -3200.2% | −1671.3 |
| FY2021 | Mar 31, 2022 | -1528.9% | +1872.0 |
| FY2020 | Mar 31, 2021 | -3400.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026CQ3 2026 | Sep 30, 2026 | -545.6% | +6680.3 |
| Q1 FY2026CQ2 2026 | Jun 30, 2026 | -13164.8% | −2872.0 |
| Q4 FY2025CQ1 2026 | Mar 31, 2026 | 12023.6% | +14751.1 |
| Q3 FY2025CQ4 2025 | Dec 31, 2025 | -13301.2% | −15179.5 |
| Q2 FY2025CQ3 2025 | Sep 30, 2025 | -7225.9% | −2082.1 |
| Q1 FY2025CQ2 2025 | Jun 30, 2025 | -10292.9% | −11485.6 |
| Q4 FY2024CQ1 2025 | Mar 31, 2025 | -2727.5% | −1052.2 |
| Q3 FY2024CQ4 2024 | Dec 31, 2024 | 1878.3% | −30869.4 |
| Q2 FY2024CQ3 2024 | Sep 30, 2024 | -5143.8% | +3198.5 |
| Q1 FY2024CQ2 2024 | Jun 30, 2024 | 1192.7% | +2542.2 |
| Q4 FY2023CQ1 2024 | Mar 31, 2024 | -1675.3% | −1552.5 |
| Q3 FY2023CQ4 2023 | Dec 31, 2023 | 32747.6% | +34812.0 |
| Q2 FY2023CQ3 2023 | Sep 30, 2023 | -8342.3% | −6015.7 |
| Q1 FY2023CQ2 2023 | Jun 30, 2023 | -1349.5% | +6333.0 |
| Q4 FY2022CQ1 2023 | Mar 31, 2023 | -122.8% | +2805.3 |
| Q3 FY2022CQ4 2022 | Dec 31, 2022 | -2064.4% | −895.4 |
| Q2 FY2022CQ3 2022 | Sep 30, 2022 | -2326.6% | −836.0 |
| Q1 FY2022CQ2 2022 | Jun 30, 2022 | -7682.5% | −6620.1 |
| Q4 FY2021CQ1 2022 | Mar 31, 2022 | -2928.1% | +436.2 |
| Q3 FY2021CQ4 2021 | Dec 31, 2021 | -1169.0% | +3370.7 |
| Q2 FY2021CQ3 2021 | Sep 30, 2021 | -1490.5% | +1185.1 |
| Q1 FY2021CQ2 2021 | Jun 30, 2021 | -1062.5% | −856.7 |
| Q4 FY2020CQ1 2021 | Mar 31, 2021 | -3364.3% | – |
| Q3 FY2020CQ4 2020 | Dec 31, 2020 | -4539.6% | – |
| Q2 FY2020CQ3 2020 | Sep 30, 2020 | -2675.6% | – |
| Q1 FY2020CQ2 2020 | Jun 30, 2020 | -205.8% | – |
See a number that looks wrong?